{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:39:54Z","timestamp":1790260794533,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NV18-03-00054"],"award-info":[{"award-number":["NV18-03-00054"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1053\/j.seminoncol.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T01:14:24Z","timestamp":1540257264000},"page":"291-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs"],"prefix":"10.1053","volume":"45","author":[{"given":"Jan","family":"Devan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Janikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Mraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.seminoncol.2018.07.005_bib0001","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004\u20132014: sub-type analyses from the UK's Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1053\/j.seminoncol.2018.07.005_bib0002","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood-2013-03-491514","article-title":"Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience","volume":"122","author":"Tan","year":"2013","journal-title":"Blood"},{"issue":"32","key":"10.1053\/j.seminoncol.2018.07.005_bib0003","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"23","key":"10.1053\/j.seminoncol.2018.07.005_bib0004","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study","volume":"33","author":"Casulo","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4706","key":"10.1053\/j.seminoncol.2018.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"6306","key":"10.1053\/j.seminoncol.2018.07.005_bib0006","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"issue":"9","key":"10.1053\/j.seminoncol.2018.07.005_bib0007","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1053\/j.seminoncol.2018.07.005_bib0008","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","article-title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","volume":"128","author":"Jurinovic","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0009","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0002-9440(10)64897-3","article-title":"Detection of BCL2 rearrangements in follicular lymphoma","volume":"160","author":"Aster","year":"2002","journal-title":"Am J Pathol"},{"issue":"4720","key":"10.1053\/j.seminoncol.2018.07.005_bib0010","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0011","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molcel.2011.10.001","article-title":"A unified model of mammalian BCL-2 protein family interactions at the mitochondria","volume":"44","author":"Llambi","year":"2011","journal-title":"Mol Cell"},{"issue":"34","key":"10.1053\/j.seminoncol.2018.07.005_bib0012","doi-asserted-by":"crossref","first-page":"14397","DOI":"10.1073\/pnas.0907555106","article-title":"The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor","volume":"106","author":"Rong","year":"2009","journal-title":"Proc Natl Acad Sci"},{"issue":"22","key":"10.1053\/j.seminoncol.2018.07.005_bib0013","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.1074\/jbc.271.22.12695","article-title":"Diminished cell proliferation associated with the death-protective activity of Bcl-2","volume":"271","author":"Borner","year":"1996","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1053\/j.seminoncol.2018.07.005_bib0014","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1200\/JCO.2013.52.8190","article-title":"t(14;18) translocation: a predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"23","key":"10.1053\/j.seminoncol.2018.07.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.254.254","article-title":"A phase 1 study of venetoclax (ABT-199 \/ GDC-0199) monotherapy in patients with relapsed\/refractory non-hodgkin lymphoma","volume":"126","author":"Gerecitano","year":"2015","journal-title":"Blood"},{"issue":"29","key":"10.1053\/j.seminoncol.2018.07.005_bib0016","doi-asserted-by":"crossref","first-page":"27388","DOI":"10.18632\/oncotarget.4489","article-title":"A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2","volume":"6","author":"Lavik","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1053\/j.seminoncol.2018.07.005_bib0017","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2018.07.005_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385991-4.00001-5","article-title":"Early steps of follicular lymphoma pathogenesis","volume":"111","author":"Roulland","year":"2011","journal-title":"Adv Immunol"},{"issue":"12","key":"10.1053\/j.seminoncol.2018.07.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2018.07.005_bib0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2013.085548","article-title":"Nature and importance of follicular lymphoma precursors","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminoncol.2018.07.005_bib0021","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.seminoncol.2018.07.005_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/leu.2016.175","article-title":"Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma","volume":"31","author":"Bouska","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminoncol.2018.07.005_bib0023","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"10","key":"10.1053\/j.seminoncol.2018.07.005_bib0024","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci"},{"issue":"43","key":"10.1053\/j.seminoncol.2018.07.005_bib0025","doi-asserted-by":"crossref","first-page":"17603","DOI":"10.1073\/pnas.1208807109","article-title":"Global identification of MLL2-targeted loci reveals MLL2\u2019s role in diverse signaling pathways","volume":"109","author":"Guo","year":"2012","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0026","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1101\/gad.275453.115","article-title":"Mutation of cancer driver MLL2 results in transcription stress and genome instability","volume":"30","author":"Kantidakis","year":"2016","journal-title":"Genes Dev"},{"issue":"10","key":"10.1053\/j.seminoncol.2018.07.005_bib0027","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"issue":"21","key":"10.1053\/j.seminoncol.2018.07.005_bib0028","article-title":"Investigating the role of MLL2 (Mll4) in B cell development","volume":"122","author":"Maniati","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminoncol.2018.07.005_bib0029","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med"},{"issue":"18","key":"10.1053\/j.seminoncol.2018.07.005_bib0030","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","article-title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","volume":"122","author":"B\u00f6d\u00f6r","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminoncol.2018.07.005_bib0031","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"issue":"25","key":"10.1053\/j.seminoncol.2018.07.005_bib0032","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1182\/blood-2012-12-473439","article-title":"A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis","volume":"123","author":"Berg","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0033","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hon.861","article-title":"Phosphorylated VEGFR2\/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation","volume":"26","author":"Giatromanolaki","year":"2008","journal-title":"Hematol Oncol"},{"issue":"7427","key":"10.1053\/j.seminoncol.2018.07.005_bib0034","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2018.07.005_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13148-016-0223-4","article-title":"Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy","volume":"8","author":"Morera","year":"2016","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0036","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1038\/bcj.2017.32","article-title":"EZH2 alterations in follicular lymphoma: biological and clinical correlations","volume":"7","author":"Huet","year":"2017","journal-title":"Blood Cancer J"},{"issue":"15","key":"10.1053\/j.seminoncol.2018.07.005_bib0037","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/nar\/gkq244","article-title":"Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes","volume":"38","author":"Pasini","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"7337","key":"10.1053\/j.seminoncol.2018.07.005_bib0038","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2018.07.005_bib0039","article-title":"CREBBP inactivation promotes the development of HDAC3 dependent lymphomas","author":"Jiang","year":"2016","journal-title":"Cancer Discov"},{"issue":"18","key":"10.1053\/j.seminoncol.2018.07.005_bib0040","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0041","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/ng1018","article-title":"Acetylation inactivates the transcriptional repressor BCL6","volume":"32","author":"Bereshchenko","year":"2002","journal-title":"Nat Genet"},{"issue":"10","key":"10.1053\/j.seminoncol.2018.07.005_bib0042","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1046\/j.1432-1327.2001.02226.x","article-title":"p300\/CBP\/p53 interaction and regulation of the p53 response","volume":"268","author":"Grossman","year":"2001","journal-title":"Eur J Biochem"},{"issue":"11","key":"10.1053\/j.seminoncol.2018.07.005_bib0043","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminoncol.2018.07.005_bib0044","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","article-title":"Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.2014.117473","article-title":"A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed\/refractory indolent non-Hodgkin lymphoma","volume":"100","author":"Chen","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminoncol.2018.07.005_bib0046","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1078-0432.CCR-15-0624","article-title":"A phase I\/II multicenter, open-label study of the oral histone deacetylase inhibitor abexinostat in relapsed\/refractory lymphoma","volume":"22","author":"Evens","year":"2016","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"10","key":"10.1053\/j.seminoncol.2018.07.005_bib0047","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1074\/jbc.M602690200","article-title":"Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor","volume":"282","author":"Radcliffe","year":"2007","journal-title":"J Biol Chem"},{"issue":"16","key":"10.1053\/j.seminoncol.2018.07.005_bib0048","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood-2015-04-640805","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood"},{"issue":"16","key":"10.1053\/j.seminoncol.2018.07.005_bib0049","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2015-04-640912","article-title":"DC-SIGN\u2013expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Amin","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminoncol.2018.07.005_bib0050","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","article-title":"Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells","volume":"108","author":"Irish","year":"2006","journal-title":"Blood"},{"issue":"20","key":"10.1053\/j.seminoncol.2018.07.005_bib0051","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2012-05-427534","article-title":"Self-antigen recognition by follicular lymphoma B-cell receptors","volume":"120","author":"Sachen","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0052","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ejh.12427","article-title":"B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells","volume":"94","author":"Seda","year":"2015","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0053","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2004.03.014","article-title":"Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling","volume":"16","author":"Fruman","year":"2004","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1053\/j.seminoncol.2018.07.005_bib0054","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-cell lymphomas: how a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2018.07.005_sbref0055","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-06-855502","article-title":"miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels","author":"Musilova","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminoncol.2018.07.005_bib0056","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2013-09-527234","article-title":"miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1","volume":"124","author":"Mraz","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminoncol.2018.07.005_bib0057","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20091962","article-title":"Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases","volume":"207","author":"Miletic","year":"2010","journal-title":"J Exp Med"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0058","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter","volume":"143","author":"Victora","year":"2010","journal-title":"Cell"},{"issue":"7502","key":"10.1053\/j.seminoncol.2018.07.005_bib0059","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature13300","article-title":"Clonal selection in the germinal center by regulated proliferation and hypermutation","volume":"509","author":"Gitlin","year":"2014","journal-title":"Nature"},{"issue":"6200","key":"10.1053\/j.seminoncol.2018.07.005_bib0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1126\/science.1257861","article-title":"Dynamic signaling by T follicular helper cells during germinal center B cell selection","volume":"345","author":"Shulman","year":"2014","journal-title":"Science"},{"issue":"6085","key":"10.1053\/j.seminoncol.2018.07.005_bib0061","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1213368","article-title":"B cell signal transduction in germinal center B cells is short-circuited by increased phosphatase activity","volume":"336","author":"Khalil","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1053\/j.seminoncol.2018.07.005_bib0062","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.3458","article-title":"Germinal center B cells recognize antigen through a specialized immune synapse architecture","volume":"17","author":"Nowosad","year":"2016","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1053\/j.seminoncol.2018.07.005_bib0063","first-page":"2993","article-title":"An in vivo reporter reveals active B cell receptor signaling in the germinal center","volume":"194","author":"Mueller","year":"2015","journal-title":"J Immunol Baltim Md 1950"},{"issue":"5","key":"10.1053\/j.seminoncol.2018.07.005_bib0064","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells","volume":"26","author":"Am\u00e9-Thomas","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3324\/haematol.2011.048132","article-title":"MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response","volume":"97","author":"Wang","year":"2012","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0066","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cell.2011.09.035","article-title":"The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma","volume":"147","author":"Oricchio","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0067","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.4428","article-title":"Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours","volume":"234","author":"Karube","year":"2014","journal-title":"J Pathol"},{"issue":"12","key":"10.1053\/j.seminoncol.2018.07.005_bib0068","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20100857","article-title":"A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling","volume":"207","author":"Hildebrand","year":"2010","journal-title":"J Exp Med"},{"issue":"21","key":"10.1053\/j.seminoncol.2018.07.005_bib0069","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.1701.1701","article-title":"Phase 2A study of copanlisib, a novel PI3K inhibitor, in patients with indolent lymphoma","volume":"124","author":"Dreyling","year":"2014","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminoncol.2018.07.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1804.1804","article-title":"Ibrutinib combined with rituximab in treatment-naive patients with follicular lymphoma: arm 1\u202f+\u202farm 2 results from a multicenter, open-label phase 2 study","volume":"128","author":"Fowler","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0071","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.3324\/haematol.2016.151738","article-title":"Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study","volume":"102","author":"Salles","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminoncol.2018.07.005_bib0072","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/leu.2010.226","article-title":"A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma","volume":"25","author":"Witzig","year":"2011","journal-title":"Leukemia"},{"issue":"15_suppl","key":"10.1053\/j.seminoncol.2018.07.005_bib0073","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.8503","article-title":"Two doses of polatuzumab vedotin (PoV, anti-CD79b antibody-drug conjugate) in patients (pts) with relapsed\/refractory (RR) follicular lymphoma (FL): durable responses at lower dose level","volume":"33","author":"Advani","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7537","key":"10.1053\/j.seminoncol.2018.07.005_bib0074","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13905","article-title":"MicroRNA silencing for cancer therapy targeted to the tumour microenvironment","volume":"518","author":"Cheng","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.seminoncol.2018.07.005_bib0076","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(10)05007-8","article-title":"BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis","volume":"105","author":"Basso","year":"2010","journal-title":"Adv Immunol"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0077","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","article-title":"BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma","volume":"102","author":"Akasaka","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminoncol.2018.07.005_bib0078","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat Immunol"},{"issue":"7360","key":"10.1053\/j.seminoncol.2018.07.005_bib0079","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1053\/j.seminoncol.2018.07.005_bib0080","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2002-11-3387","article-title":"Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma","volume":"101","author":"Pasqualucci","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminoncol.2018.07.005_bib0081","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.immuni.2015.10.015","article-title":"The FOXO1 transcription factor instructs the germinal center dark zone program","volume":"43","author":"Dominguez-Sola","year":"2015","journal-title":"Immunity"},{"issue":"18","key":"10.1053\/j.seminoncol.2018.07.005_bib0082","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2013-01-479865","article-title":"Analysis of FOXO1 mutations in diffuse large B-cell lymphoma","volume":"121","author":"Trinh","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0083","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.20161263","article-title":"The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help","volume":"214","author":"Inoue","year":"2017","journal-title":"J Exp Med"},{"issue":"7017","key":"10.1053\/j.seminoncol.2018.07.005_bib0084","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature"},{"issue":"6","key":"10.1053\/j.seminoncol.2018.07.005_bib0085","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/1078-0432.CCR-13-2175","article-title":"Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome","volume":"20","author":"Alhejaily","year":"2014","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"12","key":"10.1053\/j.seminoncol.2018.07.005_bib0086","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.humpath.2007.05.009","article-title":"Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma","volume":"38","author":"Chim","year":"2007","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1053\/j.seminoncol.2018.07.005_bib0087","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1073\/pnas.0437996100","article-title":"Transcriptional analysis of the B cell germinal center reaction","volume":"100","author":"Klein","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"20","key":"10.1053\/j.seminoncol.2018.07.005_bib0088","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/sj.onc.1201197","article-title":"Myc activation of cyclin E\/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes","volume":"14","author":"P\u00e9rez-Roger","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2018.07.005_bib0089","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1038\/ncomms9725","article-title":"miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth","volume":"6","author":"Mihailovich","year":"2015","journal-title":"Nat Commun"},{"issue":"7043","key":"10.1053\/j.seminoncol.2018.07.005_bib0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O'Donnell","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2018.07.005_sbref0091","article-title":"MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells","author":"Cerna","year":"2018","journal-title":"Leukemia"},{"issue":"21","key":"10.1053\/j.seminoncol.2018.07.005_bib0092","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0093","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ijc.28724","article-title":"Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype","volume":"135","author":"Edlefsen","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2018.07.005_bib0094","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(13)70551-5","article-title":"Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial","volume":"15","author":"Westin","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0095","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1053\/j.seminoncol.2018.07.005_bib0096","first-page":"6681","article-title":"Cross talk between follicular helper T cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment","volume":"190","author":"Rawal","year":"2013","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1","key":"10.1053\/j.seminoncol.2018.07.005_bib0097","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.23881","article-title":"Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T regulatory cells","volume":"124","author":"Ai","year":"2009","journal-title":"Int J Cancer J Int Cancer"},{"issue":"5","key":"10.1053\/j.seminoncol.2018.07.005_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155347","article-title":"Follicular lymphoma tregs have a distinct transcription profile impacting their migration and retention in the malignant lymph node","volume":"11","author":"Nedelkovska","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1053\/j.seminoncol.2018.07.005_bib0099","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.seminoncol.2018.07.005_bib0100","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-07-0778","article-title":"A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone","volume":"13","author":"Taskinen","year":"2007","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1053\/j.seminoncol.2018.07.005_bib0101","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1038\/bcj.2015.56","article-title":"IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low\/-) monocytes in B-cell non-Hodgkin lymphoma","volume":"5","author":"Xiu","year":"2015","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1053\/j.seminoncol.2018.07.005_bib0102","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1044-5323(02)00058-1","article-title":"Follicular dendritic cell-signaling molecules required for proliferation and differentiation of GC-B cells","volume":"14","author":"Li","year":"2002","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1053\/j.seminoncol.2018.07.005_bib0103","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2141.2011.08794.x","article-title":"Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin \u03b1-4-\u03b2-1 (VLA-4) with natalizumab can overcome this resistance","volume":"155","author":"Mraz","year":"2011","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1053\/j.seminoncol.2018.07.005_bib0104","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2010-03-275925","article-title":"Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a","volume":"116","author":"Lwin","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminoncol.2018.07.005_bib0105","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/s41375-018-0211-0","article-title":"Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels","volume":"32","author":"Pavlasova","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1053\/j.seminoncol.2018.07.005_bib0106","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1182\/blood-2016-04-709519","article-title":"Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4\/SDF-1 axis","volume":"128","author":"Pavlasova","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminoncol.2018.07.005_bib0107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"10.1053\/j.seminoncol.2018.07.005_bib0108","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.2014.55.5714","article-title":"Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study","volume":"33","author":"Nowakowski","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775417301288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775417301288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:54:52Z","timestamp":1758804892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775417301288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":108,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0093775417301288"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2018.07.005","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}